Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Thymosin α1 Potential treatment - clinical evidence Experimental Antiviral Oct/31/2020 1 1
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]oxane-3,4,5-triol Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020 1 0
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020 1 0
Noricaritin Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020 1 0
Ad5-nCoV Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020 4 0
Kazinol J Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020 1 0
ARCoV Potential treatment - pre-clinical evidence Experimental Vaccine Jul/23/2020 1 0